-

CALL US AT

( +1 ) 877-441-4866


Get a Call from us

call-icon

Hemodialysis Market

Kidneys remove waste products and excess fluid from the blood. When kidney function goes below 10% to 15%, it is no longer able to filter blood. This causes toxins to build up in the body along with excess fluid. If the kidneys do not function normally, this process is done by hemodialysis. Hemodialysis functions are similar to an artificial kidney in patients with kidney failure and other renal impairments. Hemodialysis uses the artificial membrane to remove waste, such as urea, from the blood, restore the proper balance of electrolytes in the blood, and eliminate extra fluid from the body. There are different types of hemodialysis: in-center hemodialysis is performed in hospitals or dialysis centers, home hemodialysis is done at home three days a week in the presence of a technician, daily home hemodialysis is done at home five to seven days a week, and nocturnal home hemodialysis is done overnight in six to eight hours.

According to the National Kidney Foundation, 10% of the global population is affected by chronic kidney disease out of which over two million people currently receive treatment with dialysis or a kidney transplant. The majority of these people are treated in only five countries U.S., Japan, Germany, Brazil, and Italy. These five countries represent only 12% of the world’s population. Only 20% are treated in about 100 developing countries which make up over 50% of the world’s population.

The global hemodialysis market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of 4% during the forecast period.


Global Hemodialysis Market Dynamics

The major drivers fueling the growth of the market are an increase in the incidence of hypertension and diabetes, rise in a number of end-stage renal disorder patients, and rise in the geriatric population.

According to the University of Maryland Medical Centre, in the US, around 4.1 million patients were treated for end-stage renal disease globally at the end of 2016, out of which about 30% are attributed to high blood pressure. Out of those 3.7 million patients, almost 3 million were undergoing dialysis treatment. Moreover, according to The Kidney Foundation of Canada, diabetes was the main cause of kidney failure in about 40% of new cases in 2017. The rising global prevalence of hypertension and diabetes is, therefore, a major growth driver for the global hemodialysis market.

Age is one of the main risk factors of chronic kidney disease. Aging affects the kidney and is responsible for structural and functional changes that affect the kidney function. In addition, the elderly are more prone to chronic diseases such as diabetes and hypertension, which are the key factors responsible for kidney impairment. According to the United Nations Population Division, the global population of individuals aged 60 years and above is expected to increase from 901 million in 2015 to 1.4 billion by 2050. The incidence of kidney disease increases after the age of 50 years and is most common after 70 years of age.



Global Hemodialysis Market Restraints

Numerous product recalls, increase in kidney transplantation and risks and complications associated with dialysis are going to restrain the market in the forecast period.

There are several side effects associated with the treatment of hemodialyses such as itching, infections, anemia, pericarditis, hyperkalemia, hypotension, hypertension, muscles cramps and bone diseases. Some of the other long-term risks involved in hemodialysis include inadequate filtering of wastes, the formation of clots in the dialysis graft or fistula, and the onset of cardiovascular disease or cardiac arrhythmias. The fear of such outcomes prevents people from undergoing hemodialysis treatment.


Global Hemodialysis Market Segmentation

The global hemodialysis market can be segmented by product type as Peritoneal Dialysis Catheter, Chronic Hemodialysis Catheter, and Acute Hemodialysis Catheter, by modality as In-Center Hemodialysis and Home Hemodialysis, by the end user as a hospital, dialysis centers, and homecare.

Chronic hemodialysis catheters accounted for the largest market share of more than 60% in 2018. Cuffed and tunneled type catheter is used for chronic hemodialysis, where access is required for more than three weeks. Chronic dialysis catheters are generally inserted in the chest or neck. Industry players are investing in advanced technologies including tip design to reduce malfunctions, infections and improve longer effectiveness. Angiodynamics, Teleflex and Medtronic offer Chronic Hemodialysis Catheters.

Home hemodialysis can be performed at home using advanced machinery. Home hemodialysis is expected to grow at a CAGR of 8.38% over the period of forecast. According to the National Kidney Foundation, in the year 2018, around 10% of the global population was affected by chronic kidney diseases, and the majority of them constitute of geriatric population. Home dialysis is affordable and also provides ease and convenience that increases its preference among the geriatric population. Home hemodialysis is expected to increase considerably with increasing services by industry players.



Global Hemodialysis Market Geographical Share

Geographically, the global hemodialysis market is divided into North America, Europe, South America, Asia-Pacific and the Middle East and Africa.

North America accounted for a dominant share of more than 35% in 2018. Among emerging markets, Asia Pacific is estimated to exhibit the highest CAGR of 10.21% over the period of forecast. North America is dominating the market due to the increasing incidence of kidney diseases,the rising number of diabetes and hypertension patients, and technological advancements in the healthcare industry. According to the National Institute of Diabetes and Digestive and Kidney Diseases Health Information Center, in 2018 over 750,000 people in the U.S. have kidney failure. Of these, 600,000 individuals are on dialysis, and roughly 150,000 live with a functioning kidney transplant. New cases of end-stage renal disease are growing with a rate of 370 per million per year in the US.

The Asia Pacific is the largest and the leading market for hemodialysis catheters. Haemodialysis catheters segment is estimated to grow at a CAGR of 8.3% over the period of forecast. Increasing prevalence of diabetes in the Asia-Pacific region ultimately affects kidney functioning and escalate the demand for dialysis treatments. Emerging economies such as India have a high prevalence of obesity and diabetes. According to the World Health Organization (WHO), around 50 million people in India suffer from diabetes, and the majority of them suffer from kidney disorders.


Global Hemodialysis Market Competitive Trends

Some of the key players in the market are Fresenius Medical Care, DaVita Healthcare Partners, Baxter International, B. Braun Melsungen, Nipro Corporation, Diaverum Deutschland GmbH, Nikkiso Co. Ltd., NxStage Medical and Angio Dynamics.

The dialysis catheters market across the globe is highly competitive with the presence of both global and local vendors. The sustainability of small manufacturers is uncertain as their revenues are entirely dependent on the demand for catheters and healthcare reforms in the country. Global manufacturers focus on enhancing their product portfolio with the use of advanced technology and more compatible materials to reduce the risk of catheter-associated blood-stream infections.

In November 2017, Baxter Canada launched hemodialysis (HDx) enabled by THERANOVA, a new therapy for hemodialysis (HD) patients that has the potential to set a new standard of renal care for the greater than 20,000 hemodialysis patients in Canada.

In January 2019, Fresenius Medical Care launched 4008A dialysis machine; the company is aiming to improve accessibility to life-sustaining dialysis treatment for patients in the countries of Asia-Pacific who are living with end-stage renal disease.


Why purchase the report?

  • Visualize the composition of the hemodialysis market across each indication, in terms of type and by type highlighting the key commercial assets and players.
  • Identify commercial opportunities in hemodialysis by analyzing trends and co-development deals.
  • Excel data sheets with thousands of data points of hemodialysis market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key products of all major market players.


Target Audience:

  • Medical device companies
  • Hospitals and clinics
  • Research and consulting firms
  • Healthcare associations/institutes
  • Venture capitalists
  • Government agencies

Global Hemodialysis Market

1. Hemodialysis Market – Methodology and Scope

1.1. Research Methodology

1.2. Research Objective and Scope of the Report

2. Hemodialysis Market – Market Definition and Overview

3. Hemodialysis Market – Executive Summary

3.1. Market Snippet by Product Type

3.2. Market Snippet by Modality

3.3. Market Snippet by End User

3.4. Market Snippet by Region

3.5. DataM CLO Scenario

4. Hemodialysis Market – Market Dynamics

4.1. Market Impacting Factors

4.1.1. Drivers

4.1.1.1. Increasing number of chronic kidney disease

4.1.1.2. Rise in dialysis centers

4.1.2. Restraints

4.1.2.1. Rise in kidney transplantation

4.1.2.2. Risk and complications in hemodialysis treatment

4.1.3. Opportunity

4.1.4. Impact Analysis

5. Hemodialysis Market – Industry Analysis

5.1. Porter's Five Forces Analysis

5.2. Supply Chain Analysis

5.3. Regulatory Analysis

5.4. Epidemiology

6. Hemodialysis Market – By Product Type

6.1. Introduction

6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment

6.1.2. Market Attractiveness Index, By Product Segment

6.2. Peritoneal Dialysis Catheter

6.2.1. Introduction

6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

6.3. Chronic Haemodialysis Catheter

6.4. Acute Haemodialysis Catheter

7. Hemodialysis Market – By Modality

7.1. Introduction

7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Segment

7.1.2. Market Attractiveness Index, By Modality Segment

7.2. In-Centre Hemodialysis

7.2.1. Introduction

7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

7.3. Home Haemodialysis      

8. Hemodialysis Market – By End User

8.1. Introduction

8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

8.1.2. Market Attractiveness Index, By End User

8.2. Hospitals

8.2.1. Introduction

8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

8.3. Dialysis Centers

8.4. Homecare

9. Hemodialysis Market – By Region

9.1. Introduction

9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

9.1.2. Market Attractiveness Index, By Region

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.2.3. Mexico

9.3. Europe

9.3.1. Germany

9.3.2. U.K.

9.3.3. France

9.3.4. Italy

9.3.5. Spain

9.3.6. Rest of Europe

9.4. South America

9.4.1. Brazil

9.4.2. Argentina

9.4.3. Rest of South America

9.5. Asia Pacific

9.5.1. China

9.5.2. India

9.5.3. Japan

9.5.4. Australia

9.5.5. Rest of Asia Pacific

9.6. Middle East and Africa

10. Hemodialysis Market – Competitive Landscape

10.1. Competitive Scenario

10.2. Competitor Hemodialysis Strategy Analysis

10.3. Comparative Product Portfolio Analysis

10.4. Market Positioning/Share Analysis

10.5. Mergers and Acquisitions Analysis

11. Hemodialysis Market Company Profiles

11.1. Fresenius Medical Care *

11.1.1. Company Overview

11.1.2. Product Portfolio and Description

11.1.3. Key Highlights

11.1.4. Financial Overview

11.2. DaVita Healthcare Partners

11.3. Baxter International

11.4. B. Braun Melsungen

11.5. Nipro Corporation

11.6. Diaverum Deutschland GmbH

11.7. Nikkiso Co. Ltd.

11.8. NxStage Medical

11.9. Angio Dynamics

12. Hemodialysis Market – Premium Insights

13. Hemodialysis Market – DataM

13.1. Appendix

13.2. About Us and Services

13.3. Contact Us

LIST OF TABLES


TABLE 01.   GLOBAL HEMODIALYSIS MARKET VALUE, 2018, 2022 & 2026 ($ MN), BY PRODUCT TYPE

TABLE 02.   GLOBAL HEMODIALYSIS MARKET VALUE 2018, 2022 & 2026 ($ MN), BY MODALITY

TABLE 03.   GLOBAL HEMODIALYSIS MARKET VALUE 2018, 2022 & 2026 ($ MN), BY END USER

TABLE 04.   GLOBAL HEMODIALYSIS MARKET VALUE 2018, 2022 & 2026 ($ MN), BY REGION

TABLE 05.   GLOBAL HEMODIALYSIS MARKET SHARE 2018, 2022 & 2026 (%), BY PRODUCT TYPE

TABLE 06.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 07.   GLOBAL HEMODIALYSIS MARKET SHARE 2018, 2022 & 2026 (%), BY MODALITY

TABLE 08.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY MODALITY, 2018–2026

TABLE 09.   GLOBAL HEMODIALYSIS MARKET SHARE 2018, 2022 & 2026 (%), BY END USER

TABLE 10.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY END USER, 2018–2026

TABLE 11.   GLOBAL HEMODIALYSIS MARKET SHARE 2018, 2022 & 2026 (%), BY REGION

TABLE 12.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY REGION, 2018–2026

TABLE 13.   NORTH AMERICA HEMODIALYSIS MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 14.   NORTH AMERICA HEMODIALYSIS MARKET VALUE ($ MN), BY MODALITY, 2018–2026

TABLE 15.   NORTH AMERICA HEMODIALYSIS MARKET VALUE ($ MN), BY END USER, 2018–2026

TABLE 16.   NORTH AMERICA HEMODIALYSIS MARKET VALUE ($ MN), BY COUNTRY, 2018–2026

TABLE 17.   SOUTH AMERICA HEMODIALYSIS MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 18.   SOUTH AMERICA HEMODIALYSIS MARKET VALUE ($ MN), BY MODALITY, 2018–2026

TABLE 19.   SOUTH AMERICA HEMODIALYSIS MARKET VALUE ($ MN), BY END USER, 2018–2026

TABLE 20.   SOUTH AMERICA HEMODIALYSIS MARKET VALUE ($ MN), BY COUNTRY, 2018–2026

TABLE 21.   EUROPE HEMODIALYSIS MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 22.   EUROPE HEMODIALYSIS MARKET VALUE ($ MN), BY MODALITY, 2018–2026

TABLE 23.   EUROPE HEMODIALYSIS MARKET VALUE ($ MN), BY END USER, 2018–2026

TABLE 24.   EUROPE HEMODIALYSIS MARKET VALUE ($ MN), BY COUNTRY, 2018–2026

TABLE 25.   ASIA PACIFIC HEMODIALYSIS MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 26.   ASIA PACIFIC HEMODIALYSIS MARKET VALUE ($ MN), BY MODALITY, 2018–2026

TABLE 27.   ASIA PACIFIC HEMODIALYSIS MARKET VALUE ($ MN), BY END USER, 2018–2026

TABLE 28.   ASIA PACIFIC HEMODIALYSIS MARKET VALUE ($ MN), BY COUNTRY, 2018–2026

TABLE 29.   MIDDLE EAST & AFRICA HEMODIALYSIS MARKET VALUE ($ MN), BY PRODUCT TYPE, 2018–2026

TABLE 30.   MIDDLE EAST & AFRICA HEMODIALYSIS MARKET VALUE ($ MN), BY MODALITY, 2018–2026

TABLE 31.   MIDDLE EAST & AFRICA HEMODIALYSIS MARKET VALUE ($ MN), BY END USER, 2018–2026

TABLE 32.   FRESENIUS MEDICAL CARE: OVERVIEW

TABLE 33.   FRESENIUS MEDICAL CARE: PRODUCT PORTFOLIO

TABLE 34.   FRESENIUS MEDICAL CARE: KEY DEVELOPMENTS

TABLE 35.   DAVITA HEALTHCARE PARTNERS: OVERVIEW

TABLE 36.   DAVITA HEALTHCARE PARTNERS: PRODUCT PORTFOLIO

TABLE 37.   DAVITA HEALTHCARE PARTNERS: KEY DEVELOPMENTS

TABLE 38.   BAXTER INTERNATIONAL: OVERVIEW

TABLE 39.   BAXTER INTERNATIONAL: PRODUCT PORTFOLIO

TABLE 40.   BAXTER INTERNATIONAL: KEY DEVELOPMENTS

TABLE 41.   B. BRAUN MELSUNGEN: OVERVIEW

TABLE 42.   B. BRAUN MELSUNGEN: PRODUCT PORTFOLIO

TABLE 43.   B. BRAUN MELSUNGEN: KEY DEVELOPMENTS

TABLE 44.   NIPRO CORPORATION: OVERVIEW

TABLE 45.   NIPRO CORPORATION: PRODUCT PORTFOLIO

TABLE 46.   NIPRO CORPORATION: KEY DEVELOPMENTS

TABLE 47.   DIAVERUM DEUTSCHLAND GMBH: OVERVIEW

TABLE 48.   DIAVERUM DEUTSCHLAND GMBH: PRODUCT PORTFOLIO

TABLE 49.   DIAVERUM DEUTSCHLAND GMBH: KEY DEVELOPMENTS

TABLE 50.   NIKKISO CO. LTD.: OVERVIEW

TABLE 51.   NIKKISO CO. LTD.: PRODUCT PORTFOLIO

TABLE 52.   NIKKISO CO. LTD.: KG: KEY DEVELOPMENTS

TABLE 53.   NXSTAGE MEDICAL: OVERVIEW

TABLE 54.   NXSTAGE MEDICAL: PRODUCT PORTFOLIO

TABLE 55.   NXSTAGE MEDICAL: KEY DEVELOPMENTS

TABLE 56.   ANGIO DYNAMICS: OVERVIEW

TABLE 57.   ANGIO DYNAMICS: PRODUCT PORTFOLIO

TABLE 58.   ANGIO DYNAMICS: KEY DEVELOPMENTS


LIST OF FIGURES


FIGURE 01.   GLOBAL HEMODIALYSIS MARKET SHARE, 2018 & 2026 (%), BY PRODUCT TYPE

FIGURE 02.   GLOBAL HEMODIALYSIS MARKET SHARE, 2018 & 2026 (%), BY MODALITY

FIGURE 03.   GLOBAL HEMODIALYSIS MARKET SHARE, 2018 & 2026 (%), BY END USER

FIGURE 04.   GLOBAL HEMODIALYSIS MARKET SHARE, 2018 & 2026 (%), BY REGION

FIGURE 05.   GLOBAL HEMODIALYSIS MARKET VALUE, 2018 - 2026 ($ MN) AND YEAR ON YEAR GROWTH

FIGURE 06.   GLOBAL HEMODIALYSIS MARKET YEAR ON YEAR GROWTH 2018 TO 2026 (%), BY PRODUCT TYPE

FIGURE 07.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY PERITONIAL DIALYSIS CATHETERS PRODUCT TYPE, 2018–2026

FIGURE 08.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY CHRONIC HEMODIALYSIS PRODUCT TYPE, 2018–2026

FIGURE 09.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY ACUTE HEMODIALYSIS PRODUCT TYPE, 2018–2026

FIGURE 10.   GLOBAL HEMODIALYSIS MARKET SHARE (%), BY PRODUCT TYPE, 2018 & 2026

FIGURE 11.   GLOBAL HEMODIALYSIS MARKET YEAR ON YEAR GROWTH 2018 TO 2026 (%), BY MODALITY

FIGURE 12.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY IN-CENTRE HEMODIALYSIS MODALITY, 2018–2026

FIGURE 13.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY HOME HEMODIALYSIS MODALITY, 2018–2026

FIGURE 14.   GLOBAL HEMODIALYSIS MARKET SHARE (%), BY MODALITY, 2018 & 2026

FIGURE 15.   GLOBAL HEMODIALYSIS MARKET YEAR ON YEAR GROWTH 2018 TO 2026 (%), BY END USER

FIGURE 16.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY HOSPITAL END USER, 2018–2026

FIGURE 17.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY DIALYSIS CENTERS END USER, 2018–2026

FIGURE 18.   GLOBAL HEMODIALYSIS MARKET VALUE ($ MN), BY HOMECARE END USER, 2018–2026

FIGURE 19.   GLOBAL HEMODIALYSIS MARKET SHARE (%), BY END USER, 2018 & 2026

FIGURE 20.   GLOBAL HEMODIALYSIS MARKET YEAR ON YEAR GROWTH 2018 TO 2026 (%), BY REGION

FIGURE 21.   NORTH AMERICA HEMODIALYSIS MARKET VALUE ($ MN), 2018–2026

FIGURE 22.   NORTH AMERICA HEMODIALYSIS MARKET SHARE (%), BY PRODUCT TYPE, 2018–2026

FIGURE 23.   NORTH AMERICA HEMODIALYSIS MARKET SHARE (%), BY MODALITY, 2018–2026

FIGURE 24.   NORTH AMERICA HEMODIALYSIS MARKET SHARE (%), BY END USER, 2018–2026

FIGURE 25.   NORTH AMERICA HEMODIALYSIS MARKET SHARE (%), BY COUNTRIES, 2018–2026

FIGURE 26.   SOUTH AMERICA HEMODIALYSIS MARKET VALUE ($ MN), 2018–2026

FIGURE 27.   SOUTH AMERICA HEMODIALYSIS MARKET SHARE (%), BY PRODUCT TYPE, 2018–2026

FIGURE 28.   SOUTH AMERICA HEMODIALYSIS MARKET SHARE (%), BY MODALITY, 2018–2026

FIGURE 29.   SOUTH AMERICA HEMODIALYSIS MARKET SHARE (%), BY END USER, 2018–2026

FIGURE 30.   SOUTH AMERICA HEMODIALYSIS MARKET SHARE (%), BY COUNTRIES, 2018–2026

FIGURE 31.   EUROPE HEMODIALYSIS MARKET VALUE ($ MN), 2018–2026

FIGURE 32.   EUROPE HEMODIALYSIS MARKET SHARE (%), BY PRODUCT TYPE, 2018–2026

FIGURE 33.   EUROPE HEMODIALYSIS MARKET SHARE (%), BY MODALITY, 2018–2026

FIGURE 34.   EUROPE HEMODIALYSIS MARKET SHARE (%), BY END USER, 2018–2026

FIGURE 35.   EUROPE HEMODIALYSIS MARKET SHARE (%), BY COUNTRIES, 2018–2026

FIGURE 36.   ASIA PACIFIC HEMODIALYSIS MARKET VALUE ($ MN), 2018–2026

FIGURE 37.   ASIA PACIFIC HEMODIALYSIS MARKET SHARE (%), BY PRODUCT TYPE, 2018–2026

FIGURE 38.   ASIA PACIFIC HEMODIALYSIS MARKET SHARE (%), BY MODALITY, 2018–2026

FIGURE 39.   ASIA PACIFIC HEMODIALYSIS MARKET SHARE (%), BY END USER, 2018–2026

FIGURE 40.   ASIA PACIFIC HEMODIALYSIS MARKET SHARE (%), BY COUNTRIES, 2018–2026

FIGURE 41.   MIDDLE EAST AND AFRICA HEMODIALYSIS MARKET VALUE ($ MN), 2018–2026

FIGURE 42.   MIDDLE EAST AND AFRICA HEMODIALYSIS MARKET SHARE (%), BY PRODUCT TYPE, 2018–2026

FIGURE 43.   MIDDLE EAST AND AFRICA HEMODIALYSIS MARKET SHARE (%), BY MODALITY, 2018–2026

FIGURE 44.   MIDDLE EAST AND AFRICA HEMODIALYSIS MARKET SHARE (%), BY END USER, 2018–2026

FIGURE 45.   FRESENIUS MEDICAL CARE: FINANCIALS

FIGURE 46.   DAVITA HEALTHCARE PARTNERS: FINANCIALS

FIGURE 47.   BAXTER INTERNATIONAL: FINANCIALS

FIGURE 48.   B. BRAUN MELSUNGEN: FINANCIALS

FIGURE 49.   NIPRO CORPORATION: FINANCIALS

FIGURE 50.   DIAVERUM DEUTSCHLAND GMBH: FINANCIALS

FIGURE 51.   NIKKISO CO. LTD.: FINANCIALS

FIGURE 52.   NXSTAGE MEDICAL: FINANCIALS

FIGURE 53.   ANGIO DYNAMICS: FINANCIALS

Buy This Report



INSTANT DELIVERY - 20% OFF

Could not find what you need?

Quick Fact: 7 of 10 customers Tailor their reports